Kent and Medway Cancer Alliance would like to thank Surrey and Sussex Cancer Alliance for allowing it to adapt the Improving Human Papillomavirus (HPV) Vaccine Uptake Toolkit which has been produced in collaboration with screening and immunisation teams and healthcare professionals across Surrey and Sussex.
It provides information, resources and practical advice to general practice teams to improve local uptake and help prevent HPV-related cancers such as cervical cancer.
Our screening and early diagnosis work focuses on breaking down barriers to increase the number of people who take up screening and raising awareness of the signs and symptoms of cancer to reduce health and health care inequalities across Kent and Medway.
The NHS Faster Diagnosis Standard (FDS) requires patients to be diagnosed or have cancer ruled out within 28 days of being referred urgently by their GP for suspected cancer. For patients who are diagnosed with cancer, it means their treatment can begin as soon as possible. For those who are not, they can have their minds put at rest more…
Personalised care means giving patients more choice and control over their care, based on what matters most to them as individuals. It is a partnership between people with cancer and their professional team.
Kent and Medway Cancer Alliance (KMCA) is one of eight cancer alliances to participate in the Galleri-GRAIL clinical trial. The trial aims to prove whether the Galleri-GRAIL test is effective in diagnosing up to 50 types of cancer by looking for DNA markers in the blood.